Home
The Latest Stories
LONDON (Reuters) - New DNA tests looking for the virus responsible for most cases of cervical cancer make sense for all women aged 30 or over, since they can prevent more cases of cancer than smear tests alone, Dutch researchers said on Thursday.
Results of a five-year study involving 45,000 women provided the strongest evidence yet in favor of using ...
LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil.
The move underscores Gardasil's lead in a $1 billion-plus worldwide market for vaccines that protect against the sexually transmitted human papillomavirus (HPV), which can cause cervical cancer.
The health ministry said Thursday ...
LONDON (Reuters) - The GAVI international immunisations group has agreed to fund the roll-out of vaccines against cervical cancer in developing countries, offering protection against a disease that kills one woman every two minutes.
Nearly 90 percent of the 275,000 deaths every year occur in poor nations, where cervical screening programs that are routine in rich nations are virtually non-existent ...
LONDON (Reuters) - Using GlaxoSmithKline's Cervarix vaccine to protect girls against the HPV virus that causes cervical cancer is so effective that health authorities could reduce the need for later cervical screening, scientists said on Wednesday.
Researchers from Finland and the United States who published two studies in The Lancet Oncology journal found Cervarix "offers excellent protection" against two key ...
NEW YORK (Reuters Health) - A new study shows heart attacks and strokes are more common in women infected with human papillomavirus, or HPV.
The research only included a small number of women with heart disease, and it doesn't prove that the sexually transmitted infection is to blame. In fact, it's still unknown whether the women already had the ...
Boys should get routinely vaccinated against human papillomavirus, a sexually transmitted disease that can lead to cancer, a US government advisory panel recommended on Tuesday.
All boys aged 11-12 should get the HPV vaccine, which is already approved for use in girls, said the recommendations from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP ...
CHICAGO (Reuters) - Boys should be routinely vaccinated against the human papillomavirus or HPV in an effort to protect them from oral, anal and penile cancers, and to extend protection of girls from cervical cancer, U.S. vaccine advisers said on Tuesday.
The Advisory Committee on Immunization Practices, which advises the U.S. Centers for Disease Control and Prevention, voted unanimously ...
US researchers have found evidence of a link between human papillomavirus infection and heart disease in women who have no other risk factors, said a first-of-its-kind study published Monday.
While the research is still in its early stages, experts said that if confirmed it could offer a promising new avenue in the fight against heart disease, which is the number ...
NEW YORK (Reuters Health) - Close to half of U.S. girls ages 13 and 17 have gotten at least one dose of the vaccine against human papillomavirus (HPV), but there is still a way to go to improve those numbers, according to researchers at the Centers for Disease Control and Prevention (CDC).
There are more than 100 strains of HPV ...
(Reuters) - Cancer of the back of the mouth and throat is on the rise, primarily because of more cases stemming from a viral infection called human papillomavirus (HPV), according to a U.S. study.
The number of people who were diagnosed with HPV-related oral cancer in 2004 was triple the number diagnosed in 1988 -- due largely, researchers suspect, to changes ...